Atom Investors LP Regenxbio Inc. Transaction History

Atom Investors LP

  • $971 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
BUY
$22.29 - $35.04 $579,227 - $910,549
25,986 Added 71.22%
62,473 $1.65 Million
Q2 2022

Aug 15, 2022
BUY
$19.35 - $35.04 $706,023 - $1.28 Million
36,487 New
36,487 $901,000
Q1 2019

May 15, 2019
SELL
$40.82 - $62.45 $298,230 - $456,259
-7,306 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$39.11 - $75.15 $285,737 - $549,045
7,306 New
7,306 $306,000

Others Institutions Holding RGNX

# of Institutions
193
Shares Held
43.5M
Call Options Held
58.9K
Put Options Held
58.4K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $404M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email